Triple-hit Lymphoma (THL)
1 clinical trials · Condition
◉ Watch Triple-hit Lymphoma (THL)
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma (NCT01742988) | Curis, Inc. | 2012-12-01 |
Track Triple-hit Lymphoma (THL) automatically
Every clearance here is in the API, with alerts when new ones post.